Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone for prevention of secondary degeneration after cerebral infarction
2021-002219-69Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferiprone in ischemic stroke and brain infarction, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Change in ipsilateral substantia nigra iron accumulation. Started May 2021; status: active.
02
Drugs
deferiprone
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on 2021-002219-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002219-69.